Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y018157 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y013348 | — |
no adverse event; product storage error; patient received PROQUAD in April or May of 2025, VARIVAX on 22-May-2025; product storage error; This spontaneous report was received from a medical assistant and a clinic manager referring to a 1-year-old male patient. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown date in April or May of 2025, the patient was vaccinated with improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (0.5 mL total, lot #Y018157, expiration date: 29-Apr-2026; rout of administration and vaccination site were not reported) for prophylaxis (Temperature: 14.85C for 30 minutes, reported by medical assistant) (Product storage error). On 22-May-2025, the patient was vaccinated with improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (1 dosage form total, lot #Y013348, expiration date: 02-Aug-2026; rout of administration and vaccination site were not reported) for prophylaxis (reported by clinic manager during follow up) (Inappropriate schedule of product administration, Product storage error) (clarify pending). As it was reported, vaccine was administered after contacting the manufacturer, and Clinic staff thought vaccine was viable. No adverse reaction was reported from patient/family. The case became valid with new information date 16-Sep-2025 due to lack of patient's identifier in previous version.
sterile diluent